Search alternatives:
gap increases » rapid increases (Expand Search), shape increases (Expand Search), _ increases (Expand Search)
non decrease » point decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), mean decrease (Expand Search)
Showing 1 - 20 results of 16,943 for search '(( significant ((non decrease) OR (nn decrease)) ) OR ( significant gap increases ))', query time: 0.75s Refine Results
  1. 1
    Anthropometric characteristics of smokers and non-smokers.

    Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Increasing gaps and decreasing returns attenuate spending effects.

    Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

    Published 2024
    Save to List
    Saved in:
  3. 3
    Respiratory clinical characteristics of smokers and non-smokers.

    Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Lung function parameters between smokers and non-smokers.

    Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019).

    Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year.

    Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Detailed treatment status of people who received non- pharmacological treatment at first diagnosis.

    Detailed treatment status of people who received non- pharmacological treatment at first diagnosis. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    NN analysis to assign the importance of variables.

    NN analysis to assign the importance of variables. by Sulmaz Ghahramani (3387635)

    Published 2022
    Save to List
    Saved in:
  9. 9
    Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later.

    Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    The gap between intentions and actions.

    The gap between intentions and actions. by Paolo Falco (11784819)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 11
    Data_Sheet_1_Significant Global Yield-Gap Closing Is Possible Without Increasing the Intensity of Environmentally Harmful Nitrogen Losses.docx

    Data_Sheet_1_Significant Global Yield-Gap Closing Is Possible Without Increasing the Intensity of Environmentally Harmful Nitrogen Losses.docx by Andrew Smerald (12416149)

    Published 2022
    Save to List
    Saved in:
  12. 12
    Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia disorder.

    Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    General information of patient who diagnosis insomnia disorder (N = 518,119).

    General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    Treatment at first diagnosis of insomnia disorder (%).

    Treatment at first diagnosis of insomnia disorder (%). by Mingee Choi (15250732)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    The table shows the significant and non-significant altered group with different parameters.

    The table shows the significant and non-significant altered group with different parameters. by Ashraf Attia Mahmoud (21262201)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.

    Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment. by Ranjeeta Adhikari (9905958)

    Published 2023
    “…<p>Traits at cellular, leaf, and whole-plant scales which were significantly different [increased (↑) or decreased (↓)] or non-significant between tolerant and sensitive cultivars in the N-deficient treatment.…”
    Save to List
    Saved in:
  17. 17
    Expression of candidate essential genes for sexualization significantly increased before the point of no return.

    Expression of candidate essential genes for sexualization significantly increased before the point of no return. by Nobuyoshi Kumagai (7829759)

    Published 2025
    Save to List
    Saved in:
  18. 18
    FNZ treatment does not cause a significant change in [Ca<sup>2+</sup>]<sub>in</sub>.

    FNZ treatment does not cause a significant change in [Ca<sup>2+</sup>]<sub>in</sub>. by Joo Hye Yeo (7378100)

    Published 2019
    Save to List
    Saved in:
  19. 19
    Significantly Enriched Pathways.

    Significantly Enriched Pathways. by Jiyong Zhang (2498740)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity.

    Treatment with pan-PKC inhibitor Gö-6983 resulted in a non-significant decrease in <i>GRK6</i> promoter activity. by Maike Stegen (8578665)

    Published 2021
    Save to List
    Saved in:

Search Tools: